SERCA2 as a cause and therapeutic target of heart failure

被引：0
|
作者：
Arai, Masashi [1 ]
机构：
[1] Gunma Univ, Dept Med & Biol Sci, Grad Sch Med, Maebashi, Gunma 3718511, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2012年 / 118卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：14P / 14P
页数：1
相关论文
共 50 条
  • [1] Cause and effect of reduced serca2 function in the failing heart
    Christensen, G
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (06) : 1011 - 1012
  • [2] Gene Therapy in Heart Failure-SERCA2a as a Therapeutic Target -
    Hayward, Carl
    Patel, Hitesh
    Lyon, Alexander
    CIRCULATION JOURNAL, 2014, 78 (11) : 2577 - 2587
  • [3] SERCA2 phosphorylation at the heart of the disease
    Brini, Marisa
    Cali, Tito
    CELL CALCIUM, 2023, 115
  • [4] Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure
    Skogestad, Jonas
    Albert, Ingrid
    Hougen, Karina
    Lothe, Gustav B.
    Lunde, Marianne
    Eken, Olav Sovik
    Veras, Ioanni
    Huynh, Ngoc Trang Thi
    Borstad, Mira
    Marshall, Serena
    Shen, Xin
    Louch, William E.
    Robinson, Emma Louise
    Cleveland, Joseph C.
    Ambardekar, Amrut V.
    Schwisow, Jessica A.
    Jonas, Eric
    Calejo, Ana I.
    Morth, Jens Preben
    Tasken, Kjetil
    Melleby, Arne Olav
    Lunde, Per Kristian
    Sjaastad, Ivar
    Carlson, Cathrine Rein
    Aronsen, Jan Magnus
    CIRCULATION, 2023, 147 (16) : 1221 - 1236
  • [5] SERCA2a: its role in the development of heart failure and as a potential therapeutic target
    Fragoso-Medina, Jorge
    Zarain-Herzberg, Angel
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2014, 5 : 43 - 54
  • [6] SERCA2 activation is beneficial in chronic heart disease
    Marshall, S.
    Borstad, M.
    Skogestad, J.
    Albert, I.
    Lothe, G.
    Espe, E.
    Zhang, L.
    Louch, W.
    Sjaastad, I.
    Aronsen, J.
    ACTA PHYSIOLOGICA, 2017, 219 : 19 - 19
  • [7] Chronic Urotensin II alters phospholamban and SERCA2 in a model of congestive heart failure
    Harris, Gregory S.
    Lust, Robert M.
    Wingard, Christopher J.
    Katwa, Laxmansa C.
    CIRCULATION, 2006, 114 (18) : 315 - 315
  • [8] SERCA2a in heart failure: Role and therapeutic prospects
    Gianni, D
    Chan, J
    Gwathmey, JK
    del Monte, F
    Hajjar, RJ
    JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 2005, 37 (06) : 375 - 380
  • [9] SERCA2a in Heart Failure: Role and Therapeutic Prospects
    Davide Gianni
    Joachim Chan
    Judith K. Gwathmey
    Federica del Monte
    Roger J. Hajjar
    Journal of Bioenergetics and Biomembranes, 2005, 37 : 375 - 380
  • [10] Heterozygous disruption of SERCA2a is not associated with impairment of cardiac performance in humans: implications for SERCA2a as a therapeutic target in heart failure
    Mayosi, BM
    Kardos, A
    Davies, CH
    Gumedze, F
    Hovnanian, A
    Burge, S
    Watkins, H
    HEART, 2006, 92 (01) : 105 - 109
12345